NCT01689857

Clinical Trial to Evaluate the Safety and Efficacy of Scarclinic™ Thin in Surgical Scars

Phase 4 Study of Scarclinic™ Thin That Treats Surgical Scars.

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Seoul National University Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Not accepted

Summary

Compare the efficacy and safety of Scarclinic™Thin and Scarclinic™ Normal for the treatment of surgical scars. Participant: 40 Treatment period : 3 months Medical device: Scarclinic™Thin , Scarclinic™ Normal Randomization: Table of random number

Detailed description

For evaluating the efficacy * The investigator check Vancouver Scar Scale at 1 and 3 month after application to evaluate vascularity, pigmentation, elasticity, height, pain and itchiness * The participant filled out survey included questions regarding convenience in use at 1 and 3 month after application.

Conditions

• Hypertrophic Surgical Scar

Interventions

Type	Name	Description
DEVICE	Scarclinic™ Thin	Apply Scarclinic™ Thin on the scar and dispense 4 ea.for each participant for 3 month.
DEVICE	Scarclinic™ Normal	Apply Scarclinic™ Normal on the scar and dispense 4 ea.for each participant for 3 month.

Timeline

• Start date: 2010-10-01
• Primary completion: 2012-07-01
• Completion: 2012-08-01
• First posted: 2012-09-21
• Last updated: 2013-04-15
• Results posted: 2013-04-15

Locations

1 site across 1 country: South Korea